LivaNova (LIVN) EBT Growth (1y) (2015 - 2026)
LivaNova (LIVN) EBT Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 17.94% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | -44.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -44.54% |
| Mar 31, 2026 | 108.71% |
| Dec 31, 2025 | -51.07% |
| Sep 30, 2025 | -23.69% |
| Jun 30, 2025 | 54.34% |
| Mar 31, 2025 | -822.94% |
| Dec 31, 2024 | 159.90% |
| Sep 30, 2024 | 2,346.76% |
| Jun 30, 2024 | 308.88% |
| Mar 31, 2024 | -450.12% |
| Dec 31, 2023 | -1,574.76% |
| Sep 30, 2023 | 98.14% |
| Jun 30, 2023 | -72.21% |
| Mar 31, 2023 | 75.40% |
| Dec 31, 2022 | 378.00% |
| Sep 30, 2022 | -155.33% |
| Jun 30, 2022 | 136.17% |
| Mar 31, 2022 | 119.83% |
| Dec 31, 2021 | 99.24% |
| Sep 30, 2021 | -122.06% |